Research and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation Division.
BRU researchers find gene that confirms existence of psoriatic arthritis
Researchers at The University of Manchester have identified genetic variants that are associated with psoriatic arthritis (PsA) but not with psoriasis, in the largest study of PsA ever published.
Manchester’s leukaemia achievements celebrated in top research report
Research has been featured in the Medical Schools Council’s Health of the Nation: The impact of UK medical schools' research report highlighting the very best medical research happening across the UK
BRU researcher awarded NIHR Clinical Lectureship
Manchester researcher John Reynolds, been awarded a prestigious NIHR Clinical Lectureship, to support his Biomedical Research Unit Small Grant funded research.
New national Rare Disease role for Professor Graeme Black
Prof Graeme Black, Strategic Director of Manchester Centre for Genomic Medicine at Saint Mary’s Hospital appointed as Theme Lead for Eye Diseases in Rare Disease Translational Research Collaboration.
University to tackle musculoskeletal disorders in the workplace
The University of Manchester is to be part of a major new research centre which will tackle the impact of musculoskeletal disorders on people’s ability to work.
New Medical Director for Manchester Clinical Research Facility
The NIHR / WT Manchester Clinical Research Facility (MCRF) is pleased to announce that on 1st November Professor Nick Webb, Consultant Paediatric Nephrologist became the new MCRF Medical Director.
BRU researcher presents findings at Arthritis Research UK PhD Conference
Amy Webster, a PhD student at The University of Manchester, presented her findings to a packed audience at the Oliver Bird-Arthritis Research UK PhD Conference at Kings College London in September.
Five blind patients with AMD will receive groundbreaking Argus II ‘bionic eye’ treatment
Second Sight Argus® II Retinal Prosthesis System to be trialled in blind dry AMD patients for the first time